您的位置: 首页 > 农业专利 > 详情页

Selective cell therapy for the treatment of renal failure
专利权人:
Wake Forest University Health Sciences
发明人:
Yoo, James,Atala, Anthony
申请号:
AU2017204345
公开号:
AU2017204345A1
申请日:
2017.06.27
申请国别(地区):
AU
年份:
2017
代理人:
摘要:
#$%^&*AU2017204345A120170713.pdf#####ASTRACT Provided herein are isolated populations of kidney cells harvested from differentiated cells of the kidney, wherein cells have been expanded in vitro. The kidney cells may include peritubular interstitial cells of the kidney, and preferably produce erythropoietin (EPO). The kidney cells may also be selected based upon EPO production. Methods of producing an isolated population of EPO producing cells are also provided, and methods of treating a kidney disease resulting in decreased EPO production in a patient in need thereof are provided, including administering the population to the patient, whereby the cells produce EPO in vivo.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充